Market Overview:
The global parathyroid hormone market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hypocalcemia and hypoparathyroidism, rising geriatric population, and growing demand for PTH drugs for the treatment of various diseases. Based on type, the global parathyroid hormone market is segmented into hypocalcemia and hypoparathyroidism. Hypocalcemia is a condition characterized by low blood calcium levels, while hypoparathyroidism is a condition characterized by low levels of PTH hormones in the body. Based on application, the global parathyroid hormone market is segmented into hospitals, clinics, and other applications. Hospitals are expected to account for a major share of this market due to rising demand for PTH drugs for treating various diseases such as renal osteodystrophy (a bone disease caused by chronic kidney failure), cancer-related bone pain (bone metastases), Paget’s disease (a disorder that results in excessive bone remodeling), and postmenopausal osteoporosis (a type of osteoporosis that occurs after menopause).
Product Definition:
Parathyroid hormone (PTH) is a peptide hormone that regulates the concentration of calcium and phosphate in the blood. It is produced by the parathyroid glands, four small glands located on the posterior surface of the thyroid gland. PTH increases serum calcium levels by promoting absorption of dietary calcium from the gastrointestinal tract and reabsorption of calcium from bone tissue. It also promotes conversion of vitamin D to its active form, which increases intestinal absorption of phosphate.
Hypocalcemia:
Hypocalcemia is a medical condition wherein there is a deficiency of calcium in the blood. The main symptoms associated with this disease are muscle spasms, pain in the bones and nerves, cramps, tetany (muscle stiffness), frequent urination, and heart arrhythmia. This disease has two types: primary hypocalcemia and secondary hypocalcemia.
Hypoparathyroidism:
Hypoparathyroidism is a medical condition in which the level of parathyroid hormone (PTH) is insufficient. It’s caused by reduced production of PTH-related peptides from cells located in the anterior pituitary gland. This results in an elevated PTH level, which has to be lowered with medication by oral or injectable drugs.
Application Insights:
Based on application, the global market is segmented into hospitals, clinics and other. Hospitals held the largest share of over 80% in 2017. Parathyroid hormone is used for treating hypocalcemia and hypoparathyroidism in hospital settings. The use of PTH leads to faster healing of bone fractures as well as improves nutritional status among patients suffering from chronic diseases such as cancer or renal failure.
Clinics are expected to be fastest-growing segment owing to increasing awareness about PTH usage among endocrinologists along with rising adoption due to its ability to treat both hypercalcemia and hypocapnia simultaneously without causing any adverse effects on heart rate or blood pressure like other medications do.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors contributing to its growth. In addition, rising incidence of osteoporosis is also expected to drive regional demand during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to an increase in awareness about parathyroid disorders and growing medical tourism industry supported by low cost treatment options offered by countries such as Japan and India.
Growth Factors:
- Increasing incidence of osteoporosis and other bone disorders: The increasing incidence of osteoporosis and other bone-related disorders is expected to drive the demand for parathyroid hormone drugs in the coming years.
- Growing geriatric population: The global geriatric population is growing at a rapid pace, which is expected to create significant opportunities for the parathyroid hormone market in the near future.
- Rising awareness about benefits of parathyroid hormone therapy: There has been a rise in awareness about the benefits of parathyroid hormone therapy among patients and healthcare professionals in recent years, which is likely to boost demand for these drugs in the coming years.
- Technological advancements: The development of novel technologies that facilitate better diagnosis and treatment of conditions associated with low levels of PTH are likely to spur growth prospects for this market over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Parathyroid Hormone Market Research Report
By Type
Hypocalcemia, Hypoparathyroidism
By Application
Hospitals, Clinics, Other
By Companies
Pfizer, Abbott Laboratories, Merck, Natpara, GlaxoSmithKline Plc, Sanofi SA, Eli Lilly, Cell Genesys Inc, OSI Pharmaceuticals, Paladin Labs Inc, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Parathyroid Hormone Market Report Segments:
The global Parathyroid Hormone market is segmented on the basis of:
Types
Hypocalcemia, Hypoparathyroidism
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Abbott Laboratories
- Merck
- Natpara
- GlaxoSmithKline Plc
- Sanofi SA
- Eli Lilly
- Cell Genesys Inc
- OSI Pharmaceuticals
- Paladin Labs Inc
- Pfizer
Highlights of The Parathyroid Hormone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hypocalcemia
- Hypoparathyroidism
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Parathyroid Hormone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Parathyroid hormone is a hormone that helps control the amount of calcium in the blood. It is produced by the parathyroid glands in the neck.
Some of the key players operating in the parathyroid hormone market are Pfizer, Abbott Laboratories, Merck, Natpara, GlaxoSmithKline Plc, Sanofi SA, Eli Lilly, Cell Genesys Inc, OSI Pharmaceuticals, Paladin Labs Inc, Pfizer.
The parathyroid hormone market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Parathyroid Hormone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Parathyroid Hormone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Parathyroid Hormone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Parathyroid Hormone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Parathyroid Hormone Market Size & Forecast, 2020-2028
4.5.1 Parathyroid Hormone Market Size and Y-o-Y Growth
4.5.2 Parathyroid Hormone Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Hypocalcemia
5.2.2 Hypoparathyroidism
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Parathyroid Hormone Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Parathyroid Hormone Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Hypocalcemia
9.6.2 Hypoparathyroidism
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Hypocalcemia
10.6.2 Hypoparathyroidism
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Hypocalcemia
11.6.2 Hypoparathyroidism
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Hypocalcemia
12.6.2 Hypoparathyroidism
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Hypocalcemia
13.6.2 Hypoparathyroidism
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Parathyroid Hormone Market: Competitive Dashboard
14.2 Global Parathyroid Hormone Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Abbott Laboratories
14.3.3 Merck
14.3.4 Natpara
14.3.5 GlaxoSmithKline Plc
14.3.6 Sanofi SA
14.3.7 Eli Lilly
14.3.8 Cell Genesys Inc
14.3.9 OSI Pharmaceuticals
14.3.10 Paladin Labs Inc
14.3.11 Pfizer
